Mangalam Drugs and Organics Ltd Performance
Day's Low
Day's High
₹103.66₹106.1352 Week's Low
52 Week's High
₹90.8₹144.99
| Returns % | |
| 1 Month Return | -8.33 % |
| 3 Month Return | -14.91 % |
| 1 Year Return | + 9.15 % |
| Market Stats | |
| Previous Close | ₹106.37 |
| Open | ₹105.06 |
| Volume | 24.57K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹168.37Cr |
Mangalam Drugs and Organics Ltd Key Statistics
| P/E Ratio | 17.91 |
| PEG Ratio | 3.01 |
| Market Cap | ₹168.37 Cr |
| P/B Ratio | 1.03 |
| EPS | 0 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | -6.15 |
Mangalam Drugs and Organics Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹168.37 Cr | 50.21% | 0.72 | -₹10 Cr | ₹368 Cr | |
| NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
| NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
| NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
| NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
About Mangalam Drugs and Organics Ltd
Share Price: ₹103.92 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹168.37Cr as of today
Revenue: ₹79.75Cr as on September 2024 (Q3 24)
Net Profit: ₹2.69Cr as on September 2024 (Q3 24)
Listing date: 23 May, 2005
Chairperson Name: Govardhan M Dhoot
| Organisation | Mangalam Drugs and Organics Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Mangalam Drugs and Organics Ltd
Mangalam Cement Reports Decline in Net Sales - 20 Nov, 2024
Mangalam Cement reported standalone net sales of Rs 359.14 crore for September 2024, reflecting a 16.13% year-on-year decline. The net profit for the period was Rs 3.28 crore, down from Rs 17.06 crore in the previous year.
Mangalam Seeds Reports Strong Growth in June 2024 - 26 Oct, 2024
Mangalam Seeds reported consolidated net sales of Rs 32.21 crore for June 2024, a 38.95% increase year-on-year. Net profit rose 35.57% to Rs 3.84 crore, with EBITDA up 21.11%. EPS increased to Rs 3.49 from Rs 2.58. However, shares have declined 21.17% over the last six months.
Mangalam Global Reports Strong Sales Growth - 22 Oct, 2024
Mangalam Global's standalone net sales for September 2024 reached Rs 517.84 crore, a 25.7% increase year-over-year. Net profit surged 2154.37% to Rs 5.54 crore.
Insights on Mangalam Drugs and Organics Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 49.47% to 49.58% in Sep 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 49.4%
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 144.8%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 0.21% to 0.11% in Sep 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 50.32% to 50.30% in Sep 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 years, MANGALAM stock has moved down by -14.3%
Mangalam Drugs and Organics Ltd Financials
Mangalam Drugs and Organics Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 50.3% | ||
| Foreign Institutions | 0.11% | ||
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 49.58% | 0.22 | |
| Others | 0% | 0.00 |
Mangalam Drugs and Organics Ltd Key Indicators
Mangalam Drugs and Organics Ltd Valuation
Mangalam Drugs and Organics Ltd in the last 5 years
Lowest (0.00x)
September 27, 2024
Today (17.91x)
November 19, 2024
Industry (54.42x)
November 19, 2024
Highest (21.50x)
September 30, 2024
Mangalam Drugs and Organics Ltd Earnings and Dividends
Mangalam Drugs and Organics Ltd Dividends December,2017
In the quarter ending September 2017, Mangalam Drugs and Organics Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.48%.
Read More about Dividends
Mangalam Drugs and Organics Ltd Technicals Summary
Bearish
Neutral
Bullish
Mangalam Drugs and Organics Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Mangalam Drugs and Organics Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Mangalam Drugs and Organics Ltd shares.
Mangalam Drugs and Organics Ltd (MANGALAM) share price today is ₹103.92
Mangalam Drugs and Organics Ltd is listed on NSE
Mangalam Drugs and Organics Ltd is listed on BSE
- Today’s highest price of Mangalam Drugs and Organics Ltd is ₹106.13.
- Today’s lowest price of Mangalam Drugs and Organics Ltd is ₹103.66.
PE Ratio of Mangalam Drugs and Organics Ltd is 17.91
PE ratio = Mangalam Drugs and Organics Ltd Market price per share / Mangalam Drugs and Organics Ltd Earnings per share
Today’s traded volume of Mangalam Drugs and Organics Ltd(MANGALAM) is 24.57K.
Today’s market capitalisation of Mangalam Drugs and Organics Ltd(MANGALAM) is ₹168.37Cr.
| Mangalam Drugs and Organics Ltd(MANGALAM | Price |
|---|---|
52 Week High | ₹144.99 |
52 Week Low | ₹90.8 |
Mangalam Drugs and Organics Ltd(MANGALAM) share price is ₹103.92. It is down -28.33% from its 52 Week High price of ₹144.99
Mangalam Drugs and Organics Ltd(MANGALAM) share price is ₹103.92. It is up 14.45% from its 52 Week Low price of ₹90.8
| Mangalam Drugs and Organics Ltd(MANGALAM | Returns |
|---|---|
1 Day Returns | -2.45% |
1 Month Returns | -8.33% |
3 Month Returns | -14.91% |
1 Year Returns | 9.15% |